Beyond Medical Technologies Closes Second Tranche of Convertible Note Financing
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the closing of the second tranche of its previously announced non-brokered private placement (the "Financing") for aggregate gross proceeds of CAD $418,750. The Company has issued senior secured, non-interest-bearing convertible notes (the "Notes") in connection with this second and final tranche.Terms of NotesThe Notes are convertible into common shares of the...
2025-06-23 10:06 AM EDT
Beyond Medical Technologies Closes First Tranche of Convertible Note Financing for $1.68 Million and Announces Rebranding to Republic Technologies
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the closing of the first tranche of its non-brokered private placement (the "Financing") for aggregate gross proceeds of CAD $1,680,000 (the equivalent of USD $1,200,000 based on an agreed exchange rate of 1.40:1) from the issuance of senior secured non-interest bearing convertible notes ("Notes").The Notes carry the following terms:Convertible into common...
2025-06-04 5:55 PM EDT
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is providing an update with respect to the management cease trade order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") on May 1, 2025, and as previously announced by the Company. The MCTO was issued by the BCSC in connection with the delay by the Company in filing its audited annual financial statements...
2025-05-15 10:26 PM EDT
Beyond Medical Technologies Announces $2.5 Million Convertible Note Financing to Support Blockchain Attestation Platform
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce a non-brokered private placement for aggregate gross proceeds of $2,500,000 (the "Financing") from the sale of the following:senior secured non-interest bearing convertible notes ("Non-Interest Bearing Notes") in the aggregate principal amount of $1,600,000 which principal amount will be convertible into common shares of the Company at the option of the holder...
2025-05-06 11:31 AM EDT
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that its application for a management cease trade order ("MCTO") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), as previously announced in a news release dated April 16, 2025, has been accepted by the British Columbia Securities Commission (the "BCSC"). The MCTO was issued by the BCSC, effective as of May...
2025-05-02 8:30 AM EDT
Beyond Medical Technologies Announces Filing of Application for Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - April 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announced today that it will likely miss its filing deadline of April 30, 2025 to file audited annual financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the financial year ended December 31, 2024 (collectively, the "Annual Filings"), as required under applicable Canadian securities laws.In connection with the Company's...
2025-04-16 7:02 PM EDT
Beyond Medical Technologies Closes Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the successful closing of its previously announced non-brokered private placement financing for total gross proceeds of for total gross proceeds of $979,232.The private placement involved the issuance of 8,987,677 units at a price of $0.109 per unit, with each unit comprising one common share in the capital of the Company....
2025-04-14 8:00 PM EDT
Beyond Medical Technologies Announces Private Placement to Advance Blockchain Infrastructure
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") today announced a non-brokered private placement of up to $1,172,600 CAD. The proceeds will be used to acquire up to 410 Ethereum (ETH) tokens to support the Company's expanding on-chain infrastructure initiatives.Under the terms of the offering, Beyond Medical will issue up to 9,020,000 common shares at a price of $0.13 per share. The securities...
2025-04-01 7:58 PM EDT
Beyond Medical Technologies Provides Business Strategy and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to provide an update on the Company's operations and business strategy. Corporate UpdateManagement ChangesIn February 2025, Company implemented a significant refresh of its executive leadership and board of directors, reflecting its strategic shift toward financial optimization, operational growth, and blockchain-integrated treasury initiatives. The following management and board changes occurred during the month:Daniel Liu...
2025-03-28 8:30 AM EDT
Beyond Medical Technologies Announces Proposed Acquisition of Elite Horizon
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Elite Horizon Management, Inc. ("Horizon") pursuant to which the Company proposes to acquire 100% of the common shares in the capital of Horizon (the "Proposed Transaction"). Beyond Medical views the Proposed Transaction as a strategic expansion into blockchain-powered medical...
2025-02-26 8:35 PM EST
Beyond Medical Technologies Closes Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the successful closing of its previously announced non-brokered private placement financing for total gross proceeds of $375,000. The Company also announces the appointment of Litong Cao as Chief Operating Officer (COO) and the resignation of Michael Kelly.The private placement involved the issuance of 7,500,000 units at a price of $0.05...
2025-02-24 7:29 PM EST
Beyond Medical Technologies Announces Debt Repayment, Board Addition, and Appointment of Interim CFO
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the successful repayment of 68.7% of its outstanding debt, the addition of Steven McAuley to its Board of Directors and the appointment of Stevenson Ty as Interim Chief Financial Officer (CFO).Beyond Medical has completed repayment of 68.7% of its debt, strengthening its balance sheet and financial stability. The Company has issued...
2025-02-13 8:45 AM EST
Beyond Medical Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce it intends to complete a non-brokered private placement (the "Offering") of up to 7,500,000 units (each, "Unit") at a price of $0.05 per Unit for aggregate gross proceeds of up to $375,000.Each Unit will consist of one common share in the capital of the Company (a "Share") and one common...
2025-02-11 8:45 AM EST
Beyond Medical Announces Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that it proposes to enter into debt settlement agreements with creditors of the Company (the "Creditors") pursuant to which the Company will agree to issue to the Creditors, and the Creditors will agree to accept, an aggregate of up to 7,900,000 common shares of the Company (the "Settlement Shares") at a deemed issue...
2025-02-06 9:15 PM EST
Beyond Medical Announces Director Change
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce that it has appointed Hongming Luo as a director of the Company. Mr. Luo brings extensive experience in the technology sector, namely focusing on AI, Blockchain and Healthcare Tech, as well as the derivatives markets. Mr. Luo replaces Harveer Sidhu, who has resigned as a director, effective February 4, 2025....
2025-02-05 2:40 AM EST
Beyond Medical Technologies Inc. Announces Management Changes and New Appointment of Daniel Liu as Chief Executive Officer and Director
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce that it has appointed Daniel Liu as Chief Executive Officer and as a director of the Company. Mr. Liu replaces Kal Malhi in these roles, following Mr. Malhi's resignation as Chief Executive Officer and as a director, effective January 30, 2025. Mr Malhi leaves Beyond Medical to pursue other ventures...
2025-02-03 6:18 PM EST
Beyond Medical Technologies Inc. Announces Resignation of Dr. Hyder A. Khoja from Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2024) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announced today the resignation of Independent Board Director, Dr. Hyder A. Khoja. "We would like to thank Dr. Khoja for his service on the Board since 2017 and wish him well in his future endeavors," expressed Kal Malhi, CEO of Beyond Medical Technologies Inc.The Board will begin a search for a new Independent Director and...
2024-08-12 4:58 PM EDT
Beyond Medical Technologies Inc. Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - February 29, 2024) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that its auditor, BF Borgers, CPA PC ("BF Borgers"), has resigned as auditor of the Company effective February 14, 2024 and the Company has filled the vacancy by appointing Charlton & Company, CPA ("Charlton").There were no reservations in BF Borger's audit reports for any financial period during which BF Borgers was the Company's auditor. There...
2024-02-29 4:58 PM EST
Beyond Medical Announces Officer Change
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2024) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that Zara Kanji-Aquino has resigned as the Chief Financial Officer of the Company. The Company would like to thank Ms. Kanji-Aquino for her contributions to the Company and wishes her well on her future endeavors. Following Ms. Kanji-Aquino's resignation, the Company has appointed Jatin Bakshi as its Chief Financial Officer and Corporate Secretary. Mr....
2024-01-24 6:36 PM EST
Beyond Medical Announces Share Consolidation
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2022) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company"), announces that effective December 30, 2022, the Company will consolidate its common shares (the "Common Shares") on a ten (10) to one (1) basis (the "Consolidation").The name of the Company and trading symbol will remain the same after the Consolidation. The new CUSIP number will be 088641204 and the new ISIN number will be CA0886412042...
2022-12-23 12:00 PM EST